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Summary
Mosquitoes represent a major and global cause of
human suffering due to the diseases they transmit.
These include parasitic diseases, i.e. malaria and
filariasis, and viral infections such as dengue, ence-
phalitis, and yellow fever. The threat of mosquito-
borne diseases is not limited to tropical and
subtropical regions of the world. Trade and climate
changes have opened new niches to tropical vectors in
temperate areas of the world, thus putting previously
unaffected regions at risk of disease transmission. The
most notable example is the spread of Aedes species,
particularly the Asian tiger mosquito Aedes albopictus
to southern Europe (reviewed in Ref. 1). Endogenous
cases of vector-borne diseases including West Nile
fever, chikungunya, and dengue are frequently being
reported, highlighting the increased risk of tropical
diseases for the European population.2–5
Typically, vector control measures targetting mos-
quitoes are in most cases carried with the use of
insecticides. This approach has a number of limi-
tations that constrain their effectiveness. Lack of
resources, inadequate logistics, and the insurgence
of insecticide resistance are some of the problems
encountered in disease-endemic countries (DECs).
More recently in Africa, the widespread use of
insecticide-treated bed nets has caused a dramatic
reduction in malaria mortality and morbidity.6
Bed nets however are a temporary solution, a tes-
timony of the failure to implement area-wide control
measures aimed at eradicating malaria. US and
Europe, with well-developed economies, have also
failed to control the spread of mosquito vectors,
particularly Aedes species.1 This alarming situation
clearly speaks for the need to expand the knowledge
on mosquito vectors and for the urgency of deve-
loping and validating novel biological and genetic
control measures that overcome the limitations of
current insecticide-based approaches. During the last
10 years, significant advances have been made in
understanding the biology, the genetics, and the
ecology of Anopheles and Aedes mosquitoes paral-
leled by the development of new molecular tools for
investigating gene function and mosquito ability to
transmit parasite and viral diseases. They offer a
compelling opportunity to design and validate new
genetic vector control measures. The size and the
complexity of this undertaking require a high level of
capacity, effort, and technological platforms. No
laboratory – or even institution – has the resources,
the infrastructure capacity, and the expertise to
accomplish this task alone.
INFRAVEC addresses the need of the scientific
community to share facilities and integrate cutting-
edge knowledge and technologies that are not readily
accessible but nevertheless critical to exploit genetic
and genomic information in the effort to control
mosquito-borne diseases. Its objective is to provide
laboratories that currently operate individually with
limited coordination and little sharing of technolo-
gies, with the collective research capacity of the la-
boratories forming the core project infrastructure.
INFRAVEC has provided resources to 31 insti-
tutions from European and African countries to
enhance collaborative links, to execute joint research
activity, and most importantly to enable individual
researchers (from PhD students to established aca-
demics) to carry complex experimental activities by
assigning research packages or ‘infrastructure access’
to be executed in the laboratory facilities and in-
frastructures of INFRAVEC. I report here on the
overall activities of INFRAVEC and its impact on
the scientific community with the purpose to initiate a
dialogue with all stakeholders on its future evolution.
Project Structure
European laboratories have made crucial contribu-
tions in the field of mosquito molecular biology,
genetics, biology, and epidemiology and have estab-
lished a number of valuable facilities to perform
Correspondence to: Andrea Crisanti, Imperial College, Department of Life
Science, London SW7 2AZ, UK. Email: acrs@imperial.ac.uk
458
 W. S. Maney & Son Ltd 2013
MORE OpenChoice articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial License 3.0
DOI 10.1179/2047772413Z.000000000174 Pathogens and Global Health 2013 VOL. 107 NO. 8
insect mass rearing, mosquito genetic manipulation,
single nucleotide polymorphism (SNP) population
typing, and confined release experiments. These
laboratories have so far mainly operated individually
with limited coordination and little sharing of
infrastructure and technologies. INFRAVEC has
the objective to integrate these facilities into a
coordinated infrastructure to promote scientific
exchanges, facilitate the sharing of technological
platforms, and enhance the research capacity of the
scientific community. Its activities are articulated in
networking, joint research projects, and promoting
Journal Publication title
PLoS Biology The interaction between a sexually transferred steroid hormone and a
female protein regulates oogenesis in the malaria mosquito Anopheles gambiae
Proceedings of the National
Academy of Sciences, USA
Wolbachia strain wMel induces cytoplasmic incompatibility and
blocks dengue transmission in Aedes albopictus
Blood A switch in infected erythrocyte deformability at the maturation
and blood circulation of Plasmodium falciparum transmission stages
Current Opinion in Microbiology An. gambiae pathogen susceptibility: the intersection
of genetics, immunity, and ecology
Mosquito/microbiota interactions
Environmental Microbiology The yeast Wickerhamomyces anomalus (Pichia anomala) inhabits
the midgut and reproductive system of the Asian
malaria vector Anopheles stephensi
Trends in Parasitology The invasive mosquito species Ae. albopictus:
current knowledge and future perspectives
PLoS Neglected Tropical Diseases Female-specific flightless (fsRIDL) phenotype for control of Ae. albopictus
PLoS ONE Culex pipiens, an experimental efficient vector of West Nile
and Rift Valley fever viruses in the Maghreb region
Identification of the midgut microbiota of An. stephensi and Anopheles
maculipennis for their application as a paratransgenic tool against malaria
High efficiency of temperate Ae. albopictus to transmit chikungunya
and dengue viruses in the southeast of France
Dissemination and transmission of the E1-226V variant of chikungunya
virus in Ae. albopictus are controlled at the midgut barrier level
Immunogenic and antioxidant effects of a pathogen-associated
prenyl pyrophosphate in An. gambiae
FEMS Microbiology Ecology Midgut bacterial dynamics in Aedes aegypti
Journal of Evolutionary Biology The impact of uniform and mixed species blood meals
on the fitness of the mosquito vector An. gambiae s.s.: does a
specialist pay for diversifying its host species diet?
Malaria Journal Comparative analyses reveal discrepancies among results
of commonly used methods for An. gambiae molecular form identification
Wide cross-reactivity between An. gambiae and Anopheles
funestus SG6 salivary proteins supports exploitation of gSG6 as
a marker of human exposure to major malaria vectors in tropical Africa
The impact of low erythrocyte density in human blood on the fitness
and energetic reserves of the African malaria vector An. gambiae s.s.
High-throughput sorting of mosquito larvae for laboratory
studies and future vector control interventions
Parasites & Vectors Molecular evidence of C. pipiens form molestus and hybrids
pipiens/molestus in Morocco, North Africa
Asaia–anopheles immune system and asaia–plasmodium
interactions: perspectives in the control of malaria infection
Insect Biochemistry and
Molecular Biology
The An. gambiae cE5, a tight- and fast-binding thrombin
inhibitor with post-transcriptionally regulated salivary-restricted expression
Microbial Biotechnology Microbial symbionts: a resource for the management of insect-related problems
BMC Microbiology Horizontal transmission of the symbiotic bacterium Asaia sp.
in the leafhopper Scaphoideus titanus Ball (Hemiptera: Cicadellidae)
Delayed larval development in Anopheles mosquitoes
deprived of Asaia bacterial symbionts
European Journal of Clinical
Microbiology and Infectious Diseases
Do mosquito-associated bacteria of the genus Asaia circulate in humans?
Pesticide Biochemistry & Physiology Insecticide resistance in the major dengue vectors
Ae. albopictus and Ae. aegypti
Antonie Van Leeuwenhoek Different mosquito species host W. anomalus (P. anomala):
perspectives on vector-borne diseases symbiotic control
Journal of Medical Entomology Mating competitiveness of Ae. albopictus radio-sterilized
males in large enclosures exposed to natural conditions
Efficiency of three diets for larval development in mass
rearing Ae. albopictus (Diptera: Culicidae)
Journal of Applied Entomology Mosquito symbioses: from basic research to the
paratransgenic control of mosquito-borne diseases
Journal of Entomological and
Acarological Research
Molecular typing of bacteria of the genus Asaia in malaria
vector Anopheles arabiensis Patton,1905
Pathogens and Global Health Symbiotic control of mosquito-borne disease
Crisanti Impact of INFRAVEC on the scientific community
Pathogens and Global Health 2013 VOL. 107 NO. 8 459
and supporting the use of the facility infrastructure
by individual researchers. Networking activities have
been aimed at improving and utilizing the facilities of
the infrastructure as well as at strengthening and
facilitating collaborative projects between institutions
to improve, assess, and validate genetically manipu-
lated mosquitoes for vector control. They include the
development and maintenance of common facilities,
such as the formation of a mosquito line repository
facility by coordinating different laboratories to stock
naturally occurring and genetically modified (GM)
mosquito lines together with the formation of a
database containing genetic and biological informa-
tion of each line.
INFRAVEC has supported four joint research and
development activities aimed at (i) improving mos-
quito gene manipulation technologies, (ii) targetting
the mosquito vectorial capacity, (iii) analyzing popu-
lation structure and gene flow in mosquito species,
and (iv) validating GM mosquitoes for vector control
under confined field conditions. These projects were
leveraged by access to the infrastructure with a range
of complementary facilities to provide the research
projects with a formidable capability to undertake
complex experimental activities. The infrastructure
of INFRAVEC consists of four laboratory facilities
based in different European countries including (i)
the insect mass rearing facilities at the Centro Agri-
coltura Ambiente in Bologna (Italy), (ii) the mosquito
genetic manipulation laboratory at Imperial College
London (UK), (iii) the mosquito confined release
facility at the Biotechnology Centre of Terni –
University of Perugia (Italy), and (iv) the bioinfor-
matics suite for data collection software development
and information sharing at EMBL-EBI Cambridge
(UK). Some of these facilities such as the bioinfor-
matics suite at EMBL-EBI are widely utilized by
the scientific community, whereas others offer their
services sporadically and without coordination.
INFRAVEC aims at integrating this infrastruc-
ture with networking activities and joint research
projects to serve the mission of overcoming the
existing capacity roadblock on the way to assess
ethical, safety, efficacy, and feasibility issues of gen-
etically manipulated mosquitoes for vector control.
INFRAVEC supports individual researchers to
carry out research packages in the infrastructure
facilities operated by the participants. The infra-
structures are made available to external researchers
or teams via a grant responsive mode. INFRAVEC
publicizes the services offered by the infrastructure to
external users and implements a peer review selection
process to identify the projects that will be given
support to utilize the infrastructure and contribute
to the further development of the joint research
activities.
Impact on the Scientific Community
INFRAVEC has been crucial for consolidating
European leadership in the field of vector biology,
for progressing towards the development of novel
genetic control measures and for assisting African
laboratories in their effort to develop independent
research profiles. This has been achieved by providing
resources for implementing research projects, for
establishing collaborative links, and for supporting
individual researchers to carry out projects in the
laboratories forming the project infrastructure facil-
ities. A number of important scientific advances have
been achieved and published on more than 30 articles
featuring on high impact scientific journals. The
following is a non-exhaustive list of publications
ordered by journal impact factor.
Crucial progresses have been made towards the
objective of understanding at the genetic level the
population structure of Anopheles gambiae mosqui-
toes culminating with the sequencing of and M and
S genetic forms and the identification of previously
unrecognized species. New sophisticated bioinfor-
matics approaches have been developed to keep
pace with unprecedented developments in sequencing
technologies. New gene manipulation technologies
have been developed that allow the selective target-
ting of mosquito genome sequences and the engineer-
ing of large mosquito populations. A confined release
Unit of access available INFRAVEC facility Units awarded




Genetically manipulated mosquitoes 4
RNA extraction 7
Microarray hybridisation experiments 6
High-throughput sequencing 18
Bioinformatic analysis of transcriptomes The Malaria Centre – SNP
Suite (Imperial College London)
8
SNPs analysis 2
Mid- and high-level production
of Aedes albopictus
Mass Rearing Laboratory
(Centro Agricoltura e Ambiente G. Nicoli)
5
Bioinformatic access European Bioinformatics Institute (EMBL) 6
Database analysis 1
Sorting of mosquitoes Confined Release Laboratory
(University of Perugia)
1
Confined medium- and large-scale release 1
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facility that can closely reproduce field environmental
conditions in terms of light exposure, humidity, and
temperature – including stochastic climate variability
– has been utilized to assess the ecology of both
field and genetically manipulated mosquitoes. A total
of 47 research projects have been granted access
involving analysis of mosquito genetics, genome
sequencing, bioinformatics, and gene manipulation
to facilitate the sharing of technological platforms
and enhance the research capacity of individual
laboratory research. Access, measured in ‘units’ or
in ‘activity packages’ (a collection of units), includes
logistical, technological, and scientific support in the
form of either service or specific training that is
normally provided to external researchers using the
given infrastructure. The table below details the units
awarded and the facility offered to them.
INFRAVEC has also promoted the formation of
a mosquito line repository facility by coordinating
different laboratories to stock, in their insectaries,
naturally occurring and genetically modified mos-
quito lines together with the formation of a data-
base containing genetic and biological information of
each line. Coordination ensures that agreed standards
have been implemented across different laboratories
and that external users may have access to a unique
collection of mosquito lines upon request through
the INFRAVEC website. INFRAVEC has also sup-
ported the development of a high-throughput tech-
nology for the automated sorting of large numbers
of mosquitoes. A sorting instrument has been deve-
loped in collaboration with Union Biometrica Inc. to
separate hundreds of thousands of mosquito larvae
daily on the basis of the expression of fluorescent
markers in tissues and organs. This technology has
proven extremely useful to dramatically increase the
yield of mass rearing and the throughput of genetic
screens.
Future Development
In response to a call for letters of intent published
last year by the EU infrastructure programme,
the principal investigators of the INFRAVEC core
facilities have presented a proposal for renewal.
The new proposal, while maintaining the overall
INFRAVEC architecture combining infrastructure
facilities, for transnational access and services, with
networking and research activities, for integrating the
efforts of the research community, brings important
novelties that take into account the development of
new technologies, the scientific progress, and the
enhanced research capacity of the scientific commu-
nity. Additional facilities have been included that
provide an enhanced and unique research capacity
for (1) investigating the ability of mosquito species to
transmit a variety of viral and parasitic diseases, (2)
performing new cost-effective mosquito genotyping
analysis and phenotypic associations, (3) accessing
next-generation sequencing technologies, and (4)
carrying out release studies under confined condi-
tions. Such enhanced infrastructure capacity will be
mobilized towards the development of networking
and research activities that have the objective to (1)
generate a European risk map for viruses potentially
transmitted by Aedesmosquitoes, (2) validate the cost
effectiveness and the safety of GM mosquitoes for
vector control, and (3) investigate how the interaction
of mosquitoes with environment microbiota shapes
their vectorial capacity.
Networking activities will involve the strengthen-
ing of the existing multicentre mosquito repository
to include the phenotypic and genotypic character-
ization of more than 100 mosquito lines of different
genetic backgrounds as well as their genome sequen-
cing. A database will also be created to facilitate
the association of genotypic variant with biological
relevant phenotypes. The project’s main mission will
again focus on providing resources to researchers at
all levels of their career in a bottom-up response
mode to carry out experimental activities in the core
facility laboratories in the form of self-contained
research packages or ‘access units’. Access units or
research packages will focus on two mosquito species
of great medical and environmental relevance: the
human malaria vector An. gambiae, and the world’s
most invasive species, Ae. albopictus, which can
function as a vector for a variety of viral diseases,
including dengue fever and chikungunya.
The wider scientific community will access the
following facilities: (1) the high security P3 insectary
of Institut Pasteur for investigating the ability of
mosquito species and strains from different genetic
backgrounds and/or experimentally manipulated to
transmit a number of parasitic and viral diseases;
(2) the next-generation sequencing facility of the
University of Perugia for analyzing the transcrip-
tion repertoire of mosquito tissues and organs, and
sequencing laboratory and field mosquito genomes;
(3) the bioinformatic suite of EMBL-EBI for acquir-
ing expertise in software development and data
analysis, and extracting functional information from
sequence data. This will also involve a helpdesk to
follow the users in their bioinformatic learning curve,
including on-site visits and consultations; (4) the
genetic laboratory at Imperial College to genetically
engineer mosquitoes for assessing gene function, and
develop mosquito lines suitable for genetic vector
control; (5) the confined release facility at the Uni-
versity of Perugia to assess and validate, under
conditions that reproduce the field environment,
the safety and effectiveness of genetically manipu-
lated mosquitoes for vector control; and (6) the field
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facilities of International Centre of Insect Physiology
and Ecology to study the ecology and the beha-
viour of mosquito strains in natural and controlled
environments. This combination has no equal in the
world scientific landscape. It will offer the research
community an unprecedented research power well
beyond individual capacities, and will place Europe
in the forefront of global research and translation
on vector-borne human disease. In theory, a single
project may include complex experimental workflow
involving genetic transformation of mosquito species,
their phenotypic analysis in semi-field conditions, and
functional transcription analysis. The overall objec-
tive is to progressively transform research activities in
commodities and change the way research is carried
out from time consuming and laboratory intensive to
mainly conceptual methods.
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